Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Leiomyoma × ferrous sulfate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Anemia 2 Postoperative Complications 1 Leiomyoma 1 Iron Deficiencies 1 Colorectal Neoplasms 1 Adenocarcinoma 1

Interventions

ulipristal acetate 9 Leuprolide 4 Uterine Artery Embolization 3 ulipristal 2 Tranexamic Acid 2 Letrozole 2 Bupivacaine 2 ferrous sulfate 1 elagolix 1 dienogest 1 cetrorelix 1 Vitamin B 6 1 Uterine Myomectomy 1 Sodium Chloride 1 Sirolimus 1 Saline Solution 1 Rocuronium 1 Pregabalin 1 Oxytocin 1 Naproxen 1 Misoprostol 1 Mifepristone 1 Lidocaine 1 Ibuprofen 1 Goserelin 1 Gonadotropin-Releasing Hormone 1 DMAC2L protein, human 1 Celecoxib 1 Anesthetics, Local 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02825719 2020-04-09

Ulipristal Use in Chinese Population

Queen Mary Hospital, Hong Kong

Phase 4 Terminated

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡